2 Monster Stocks Worth Holding for the Next Decade
Source: Nasdaq

The article highlights Coca-Cola and Altria as long-term income holdings, citing 64 and 57 consecutive years of dividend increases, respectively. Coca-Cola is up 27.8% year-to-date with a 2.3% yield, supported by an asset-light bottling model and stronger profitability than PepsiCo despite lower revenue. Altria has risen 20.5% year-to-date and 75% since the start of 2024, while maintaining a 6% dividend yield through pricing increases that offset declining cigarette volumes.
Analysis
This is unlikely to be a durable near-term catalyst: both KO and MO have already benefited from the 2026 preference for cash-generative defensives, leaving valuation and rates—not dividend-streak marketing—as the marginal drivers. KO's asset-light concentrate economics support superior incremental margins, but its premium versus PEP requires sustained pricing/mix and emerging-market volume resilience; any shift toward private-label value consumption or FX headwinds would expose the multiple. PEP is the more operationally levered turnaround candidate if snacks stabilize, while KO remains the lower-volatility quality compounder.
MO's yield is compensation for a shrinking combustibles base and elevated regulatory/transition risk, not simply an income premium. Price increases can protect revenue while accelerating downtrading, illicit-market migration, and eventual volume elasticity; the key 6-18 month variable is whether smoke-free profits scale fast enough to offset this negative mix rather than merely produce revenue growth. A lower-rate rally can further compress MO's yield, but that is a weak foundation if nicotine regulation tightens or Njoy investment fails to earn its cost of capital.
Contrarian view: the better risk-adjusted expression may be relative rather than outright long exposure. Consensus treats KO as a bond proxy and MO as a high-yield bond; both become vulnerable together if real yields rise, but KO has materially cleaner terminal-value visibility. The article's claims do not provide current organic-volume, payout-ratio, or valuation data, so there is no basis for a fresh directional position solely on this publication.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.32
Ticker Sentiment
Key Decisions for Investors
- Maintain KO as a defensive/core long only on a pullback or following confirmation of positive unit-case volume and stable gross-margin guidance at the next earnings print; target a 6-12 month hold. Exit/reduce if organic volume turns negative for two consecutive quarters or management cuts full-year pricing/mix expectations.
- Use a 3-6 month pair: long KO / short PEP in equal beta-adjusted dollars if beverage volumes remain resilient while PEP's North American snack elasticity persists. Thesis is margin-quality divergence; stop if PEP restores organic sales growth and margin guidance while KO's volume decelerates.
- Do not chase MO after the yield compression. Reassess only if its forward dividend yield widens materially versus its recent range without a corresponding deterioration in adjusted EPS coverage; require evidence of smoke-free gross-profit contribution, not just shipment/revenue growth, before adding.
- For portfolios needing tobacco income exposure, hedge sector-specific regulatory risk with a modest long KO versus MO position rather than treating MO's headline yield as a standalone return source. Review around FDA nicotine/product-rule milestones and MO quarterly combustibles-volume trends.
More News
- The Competition's Response to Tesla Robotaxi Day
- Why Forgent Power Stock Keeps Going Up
- Micron vs. Sandisk: Which AI Memory Stock Benefits More From Nvidia's $279 Billion Warning?
- Salesforce’s Marc Benioff to AI industry: Regulate yourselves or get sued
- Anthropic IPO Date: What Investors Need to Know Before It Prices
- Vistra vs. Constellation vs. Talen Energy: Which Nuclear-Heavy Stock Is the Better AI-Power Bet?
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- What Is an AI Research Agent?
- Bitcoin's 52% Crash Proves It's a Tech Stock: Here's What That Means for Portfolio Construction